Artichol film-coated tablets 400 mg blister No. 40

Instructions Artihol film-coated tablets 400 mg blister No. 40

Composition

active ingredient: artichoke dry extract;

1 tablet contains 400 mg of artichoke dry extract;

excipients: heavy magnesium oxide, colloidal anhydrous silicon dioxide, corn starch, talc, magnesium stearate;

shell: Opadry 200 Brown film coating mixture: polyvinyl alcohol, talc, titanium dioxide (E 171), polyethylene glycol, yellow iron oxide (E 172), red iron oxide (E 172), black iron oxide (E 172), methacrylate copolymer (type C), sodium bicarbonate.

Dosage form

Film-coated tablets.

Main physicochemical properties: round tablets with a biconvex surface, coated with a light brown film coating.

Pharmacotherapeutic group

Drugs affecting the digestive system and metabolism. Drugs used to treat liver and biliary tract diseases. Drugs used in biliary pathology. ATC code A05A X.

Pharmacological properties

Pharmacodynamics

Pharmacological properties are due to the action of a complex of biologically active substances that are part of the leaves of the field artichoke. It has a choleretic, hepatoprotective and diuretic effect, and also reduces the content of urea in the blood. Inulin and other components contained in the artichoke improve metabolic processes in the body.

Pharmacokinetics

The action of the drug Artihol is the combined effect of its components, therefore kinetic observations are impossible; all components together cannot be traced using markers or bioassays. For the same reason, it is impossible to detect the metabolites of the drug.

Indication

Chronic hepatitis, cirrhosis of the liver, chronic non-calculous cholecystitis, hypokinetic biliary dyskinesia, chronic nephritis, chronic renal failure.

Contraindication

Hypersensitivity to the components of the drug, to plants of the Asteraceae family; biliary obstruction, cholangitis, suppuration (empyema) of the gallbladder, cholelithiasis or other biliary tract diseases, acute liver diseases, severe liver failure; urinary tract obstruction, acute kidney diseases.

Interaction with other medicinal products and other types of interactions

Unknown.

Application features

Use with caution in diseases that may lead to biliary obstruction and in severe liver disease. If diarrhea or abdominal pain occurs, treatment should be discontinued and a doctor should be consulted.

Ability to influence reaction speed when driving vehicles or other mechanisms

The drug does not affect the reaction speed when driving or working with other mechanisms.

Use during pregnancy or breastfeeding

During pregnancy or breastfeeding, the drug should be used only as prescribed by a doctor if the expected benefit to the mother outweighs the potential risk to the fetus or child.

Method of administration and doses

Apply internally to adults and children over 6 years of age. Apply before meals.

Adults and children over 12 years of age should be prescribed 200-400 mg 3 times a day.

Children aged 6-12 years - 200 mg 3 times a day.

The course of treatment is determined by the doctor individually, depending on the nature and course of the disease. Usually the course of treatment is 2-3 weeks. Repeated courses of treatment are possible after consultation with the doctor.

Children

Use in children over 6 years of age as prescribed by a doctor.

Overdose

Possible increased side effects.

Adverse reactions

In case of prolonged use of the drug in high doses, diarrhea is possible, as well as abdominal cramps, stomach upset, nausea, and heartburn.

Allergic reactions are possible, including urticaria, skin rashes, hyperemia, itching.

Expiration date

3 years.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging

400 mg tablets: 10 tablets in a blister, 4 blisters in a pack.

Vacation category

Without a prescription.

Producer

JSC "KYIV VITAMIN FACTORY".

Location of the manufacturer and its business address

04073, Ukraine, Kyiv, Kopylivska St., 38.